New Pill From Merck Could Slash Cholesterol Levels, Trials Show

The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease ...
Healio

Olezarsen reduces triglycerides, cutting pancreatitis risk by 85%

Monthly olezarsen reduced triglycerides by 65% for people with severe hypertriglyceridemia, resulting in a greater than 85% ...
The New England Journal of Medicine

Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk

Patients with severe hypertriglyceridemia have an increased risk of acute pancreatitis. The efficacy and safety of olezarsen, ...
The American Journal of Managed Care

Oral PCSK9 Inhibitor Enlicitide Matches Injectables in Lowering LDL Cholesterol

Navar A. Efficacy and safety of enlicitide, an oral PCSK9 inhibitor, for lowering LDL cholesterol in adults with or at-risk for ASCVD: the phase 3 CORALreef lipids trial. Presented at: AHA 2025 ...